The Journal of Immunology, Vol 155, Issue 3 1565-1574, Copyright © 1995 by American Association of Immunologists

ARTICLES

HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite- induced monokines

RT Gazzinelli, S Bala, R Stevens, M Baseler, L Wahl, J Kovacs and A Sher
Immunobiology Section, CCM/CC, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Individuals infected with Toxoplasma gondii normally develop resistance to the parasite, resulting in an asymptomatic chronic infection. In AIDS patients, this resistance is lost leading to reactivation of infection and development of encephalitis. To characterize the cytokine response of T. gondii-infected individuals, PBMC were cultured in vitro in the presence or absence of crude tachyzoite Ags (STAg). When stimulated with STAg, PBMC from T. gondii-infected donors, but not controls, produced high levels of Type 1 lymphokines (IL-2 and IFN- gamma) as well as the monokine IL-12, in the absence of detectable Type 2 lymphokines (IL-4 and IL-5). In contrast, cells of individuals from both groups produced high levels of IL-1, IL-6, and TNF-alpha when exposed to the same Ag preparation. By using highly purified elutriated cells, we demonstrated that monocytes are a major source of these monokines. The above findings were further expanded by analyzing the cytokine responses induced by STAg in PBMC from patients co-infected with T. gondii and HIV. Our results demonstrate that parasite-specific IL-2 and IFN-gamma responses are greatly impaired even before AIDS development, as is IL-12 synthesis by PBMC from HIV-infected individuals stimulated with STAg. In contrast, the release of IL-6 and TNF-alpha triggered by STAg is either not affected or augmented during HIV infection.

This article has been cited by other articles:

				A. A. Byrnes, D. M. Harris, S. F. Atabani, B. P. Sabundayo, S. J. Langan, J. B. Margolick, and C. L. Karp Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy J. Leukoc. Biol., December 1, 2008; 84(6): 1447 - 1453. [Abstract] [Full Text] [PDF]

				G. R. de Arquer, R. Pena, C. Cabrera, G. Coma, R. Ruiz-Hernandez, R. Guerola, B. Clotet, L. Ruiz, J. A. Este, M. L. Calle, et al. Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients J. Leukoc. Biol., July 1, 2007; 82(1): 72 - 78. [Abstract] [Full Text] [PDF]

				V. Michailowsky, N. M. Silva, C. D. Rocha, L. Q. Vieira, J. Lannes-Vieira, and R. T. Gazzinelli Pivotal Role of Interleukin-12 and Interferon-{gamma} Axis in Controlling Tissue Parasitism and Inflammation in the Heart and Central Nervous System during Trypanosoma cruzi Infection Am. J. Pathol., November 1, 2001; 159(5): 1723 - 1733. [Abstract] [Full Text] [PDF]

				M. C. Braun, J. M. Wang, E. Lahey, R. L. Rabin, and B. L. Kelsall Activation of the formyl peptide receptor by the HIV-derived peptide T-20 suppresses interleukin-12 p70 production by human monocytes Blood, June 1, 2001; 97(11): 3531 - 3536. [Abstract] [Full Text] [PDF]

				X. Ma and L. J. Montaner Proinflammatory response and IL-12 expression in HIV-1 infection J. Leukoc. Biol., September 1, 2000; 68(3): 383 - 390. [Abstract] [Full Text] [PDF]

				I. Prigione, P. Facchetti, L. Lecordier, D. Deslee, S. Chiesa, M.-F. Cesbron-Delauw, and V. Pistoia T Cell Clones Raised from Chronically Infected Healthy Humans by Stimulation with Toxoplasma gondii Excretory-Secretory Antigens Cross-React with Live Tachyzoites: Characterization of the Fine Antigenic Specificity of the Clones and Implications for Vaccine Development J. Immunol., April 1, 2000; 164(7): 3741 - 3748. [Abstract] [Full Text] [PDF]

				G. Reichmann, W. Walker, E. N. Villegas, L. Craig, G. Cai, J. Alexander, and C. A. Hunter The CD40/CD40 Ligand Interaction Is Required for Resistance to Toxoplasmic Encephalitis Infect. Immun., March 1, 2000; 68(3): 1312 - 1318. [Abstract] [Full Text] [PDF]

				J. D. Marshall, J. Chehimi, G. Gri, J. R. Kostman, L. J. Montaner, and G. Trinchieri The Interleukin-12-Mediated Pathway of Immune Events Is Dysfunctional in Human Immunodeficiency Virus-Infected Individuals Blood, August 1, 1999; 94(3): 1003 - 1011. [Abstract] [Full Text] [PDF]

				G. A. Dean and N. C. Pedersen Cytokine Response in Multiple Lymphoid Tissues during the Primary Phase of Feline Immunodeficiency Virus Infection J. Virol., December 1, 1998; 72(12): 9436 - 9440. [Abstract] [Full Text] [PDF]

				E. Y. Denkers and R. T. Gazzinelli Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection Clin. Microbiol. Rev., October 1, 1998; 11(4): 569 - 588. [Abstract] [Full Text] [PDF]

				J. A. Mikovits, H. A. Young, P. Vertino, J.-P. J. Issa, P. M. Pitha, S. Turcoski-Corrales, D. D. Taub, C. L. Petrow, S. B. Baylin, and F. W. Ruscetti Infection with Human Immunodeficiency Virus Type 1 Upregulates DNA Methyltransferase, Resulting in De Novo Methylation of the Gamma Interferon (IFN-gamma ) Promoter and Subsequent Downregulation of IFN-gamma Production Mol. Cell. Biol., September 1, 1998; 18(9): 5166 - 5177. [Abstract] [Full Text]

				T. R. Johnson, J. E. Johnson, S. R. Roberts, G. W. Wertz, R. A. Parker, and B. S. Graham Priming with Secreted Glycoprotein G of Respiratory Syncytial Virus (RSV) Augments Interleukin-5 Production and Tissue Eosinophilia after RSV Challenge J. Virol., April 1, 1998; 72(4): 2871 - 2880. [Abstract] [Full Text] [PDF]

				L. Meyaard, E. Hovenkamp, N. Pakker, T. C.T.M. van der Pouw Kraan, and F. Miedema Interleukin-12 (IL-12) Production in Whole Blood Cultures From Human Immunodeficiency Virus-Infected Individuals Studied in Relation to IL-10 and Prostaglandin E2 Production Blood, January 15, 1997; 89(2): 570 - 576. [Abstract] [Full Text] [PDF]